Optimi Health Corp. (CSE:OPTI)
7.84
-0.36 (-4.39%)
May 21, 2026, 3:59 PM EST
Optimi Health Revenue
Optimi Health had revenue of 193.60K CAD in the twelve months ending December 31, 2025, down -62.59% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth.
Revenue (ttm)
193.60K
Revenue Growth
-62.59%
P/S Ratio
238.29
Revenue / Employee
24.20K
Employees
n/a
Market Cap
46.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 193.99M |
| Rubicon Organics | 60.76M |
| C21 Investments | 45.62M |
| MediPharm Labs | 43.28M |
| LSL Pharma Group | 26.80M |
| Greenway Greenhouse Cannabis | 9.13M |
| Red Light Holland | 4.17M |
Optimi Health News
- 7 hours ago - Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering - Newsfile Corp
- 11 hours ago - SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) - GlobeNewsWire
- 1 day ago - Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - Newsfile Corp
- 4 weeks ago - Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing - Newsfile Corp
- 4 weeks ago - Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products - Newsfile Corp
- 2 months ago - Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering - Newsfile Corp
- 3 months ago - Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia - Newsfile Corp
- 3 months ago - Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression - Newsfile Corp